Skip to main navigation
Skip to search
Skip to main content
Projects and Grants
Press / Media
Fellowships, Honors, and Prizes
A Rollover protocol to Allow Continued Access to Tivozan
Medicine - Hematology, Oncology, Transplant
A Rollover protocol to Allow Continued Access to Tivozanib Hydrochloride (AV-951) for Subjects Enrolled in Other Tivozanib Hydrochloride Protocols
Effective start/end date
AVEO PHARMACEUTICALS, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Medicine & Life Sciences